True Wealth Design’s BioNTech BNTX Stock Holding History

True Wealth Design’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,630	Closed	-$696K	–	863
2022 Q4	$696K	Buy	+4,630	New	+$712K	0.32%	89

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

True Wealth Design's BNTX Position: Q1 2023 in Review

True Wealth Design sold out of BioNTech (BNTX) in Q1 2023, closing a stake of 4,630 shares — an estimated $696K sold.

True Wealth Design first reported a position in BNTX in Q4 2022 and held it in 1 quarter. The position peaked at $696K in Q4 2022. 282 funds tracked by Wall St. Rank hold BNTX as of Q1 2023.

True Wealth Design reported no remaining BioNTech position as of Q1 2023 after selling out during the quarter.
True Wealth Design sold 4,630 BioNTech shares in Q1 2023, an estimated $696K.
True Wealth Design first reported a position in BioNTech in Q4 2022 and held it in 1 quarter.
True Wealth Design's BioNTech position peaked at $696K in Q4 2022.
282 funds tracked by Wall St. Rank held BioNTech as of Q1 2023.

Based on True Wealth Design's 13F filing for Q1 2023, filed 12 May 2023.